Biocryst Pharmaceuticals (BCRX) Total Non-Current Liabilities (2010 - 2019)
Biocryst Pharmaceuticals' (BCRX) quarterly Total Non-Current Liabilities came in at $87.0 million in Q3 2019, down 22.77% on a QoQ basis from $112.6 million in Q2 2019.
Biocryst Pharmaceuticals (BCRX) Total Non-Current Liabilities (2010 - 2019) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has 8 years of Total Non-Current Liabilities data on file, last reported at $87.0 million in Q3 2019.
- Quarterly Total Non-Current Liabilities changed N/A year-over-year to $87.0 million in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $87.0 million (changed N/A YoY) and the FY2018 annual result came in at $144.1 million, changed N/A from the prior year.
- Total Non-Current Liabilities slipped to $87.0 million in Q3 2019, from $112.6 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $144.1 million in Q4 2018 to a low of $81.2 million in Q2 2016.
- A 3-year average of $108.8 million and a median of $101.1 million in 2016 frame the typical range for Total Non-Current Liabilities.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.45 Bn | 43.48 Bn | - | -13.28 Bn |
| 2 | Teva Pharmaceutical Industries | 43.60 Bn | 39.95 Bn | 2.15 Bn | 16.45 Bn |
| 3 | Zoetis | 32.45 Bn | 30.77 Bn | 1.05 Bn | 11.64 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 33.50 Bn |
| 5 | United Therapeutics | 22.06 Bn | 19.40 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.99 Bn | 18.10 Bn | 1.46 Bn | 18.76 Bn |
| 7 | Neurocrine Biosciences | 15.52 Bn | 15.13 Bn | 935.80 Mn | 1.37 Bn |
| 8 | Elanco Animal Health | 11.98 Bn | 11.45 Bn | 798.00 Mn | 6.42 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 334.00 Mn |
| 10 | Biocryst Pharmaceuticals | 2.43 Bn | 2.08 Bn | 214.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 86.96 Mn |
| Jun 30, 2019 | 112.60 Mn |
| Mar 31, 2019 | 138.45 Mn |
| Dec 31, 2018 | 144.14 Mn |
| Sep 30, 2016 | 89.60 Mn |
| Jun 30, 2016 | 81.24 Mn |
| Jun 30, 2014 | 139.17 Mn |
| Mar 31, 2014 | 42.41 Mn |
| Dec 31, 2013 | 48.87 Mn |
| Sep 30, 2013 | 51.62 Mn |
| Jun 30, 2013 | 38.24 Mn |
| Mar 31, 2013 | 44.11 Mn |
| Dec 31, 2012 | 52.69 Mn |
| Sep 30, 2012 | 58.56 Mn |
| Jun 30, 2012 | 71.28 Mn |
| Mar 31, 2012 | 76.12 Mn |
| Dec 31, 2011 | 78.21 Mn |
| Sep 30, 2011 | 89.59 Mn |
| Jun 30, 2011 | 106.07 Mn |
| Dec 31, 2010 | 109.45 Mn |